Treace Medical Concepts (TMCI) Amortization of Deferred Charges (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Amortization of Deferred Charges data on file, last reported at $262000.0 in Q1 2026.

• Quarterly Amortization of Deferred Charges rose 254.05% year-over-year to $262000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $480000.0 (up 61.62% YoY) and the FY2025 annual result came in at $292000.0, down 2.01% from the prior year.
• Amortization of Deferred Charges advanced to $262000.0 in Q1 2026, from $69000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $262000.0 in Q1 2026 to a low of $45000.0 in Q1 2022.
• A 5-year average of $81941.2 and a median of $74000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
• Annual changes were most pronounced in 2025 — Amortization of Deferred Charges declined 8.0% — and 2026, when it surged 254.05%.
• Tracing TMCI's Amortization of Deferred Charges over 5 years: stood at $75000.0 in 2022, then dropped by 1.33% to $74000.0 in 2023, then increased by 1.35% to $75000.0 in 2024, then slipped by 8.0% to $69000.0 in 2025, then soared by 279.71% to $262000.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $262000.0 (Q1 2026), $69000.0 (Q4 2025), and $75000.0 (Q3 2025), per Business Quant data.